Calidi Biotherapeutics raises funds from 2 Korean firms

Korea |  News | 0 Comment | 22 Jan, 2020

US based Calidi Biotherapeutics, Inc., a clinical‐stage immuno-oncology company at the forefront of cell-based oncolytic virus immunotherapies for cancer has announced Series A ...Read more

KT, Samsung Medical Center create 5G-powered smart hospitals

Korea |  News | 0 Comment | 21 Jan, 2020

KT Corporation, Korea's largest telecommunications company, and the Samsung Medical Center (SMC) announced last week that they have jointly developed an innovative, 5G-powered medical servi...Read more

Bridge Biotherapeutics gets FDA IND clearance for lung cancer drug

Korea |  News | 0 Comment | 20 Jan, 2020

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U....Read more

Hanmi Pharma to develop innovative drugs for rare diseases

Korea |  News | 0 Comment | 16 Jan, 2020

The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference in San Francisco during Jan...Read more

Korea creates smart LED contact lens to diagnose diabetes

Korea |  News | 0 Comment | 17 Jan, 2020

Diabetic patients need to measure their blood-sugar level by drawing blood before and after a meal and it is easy to develop complications due to diabetes. Recently, a research team from So...Read more

A2A, Daewoong to co-develop novel oncology treatments

Korea |  News | 0 Comment | 16 Jan, 2020

A2A Pharmaceuticals Inc. (A2A) announced an agreement to design and co-develop oncology drug candidates with Daewoong Pharmaceutical Co., Ltd. (Daewoong), a major pharmaceutical company in ...Read more

Genome & Company inks clinical trial collaboration

Korea |  News | 0 Comment | 15 Jan, 2020

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced that it has entered into a clinical trial collaboration and supply agre...Read more

Macrogen inks license and supply agreement with Thermo Fisher

Korea |  News | 0 Comment | 14 Jan, 2020

Kap-Seok Yang, CEO of Macrogen has announced that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The agreement, which was recently ...Read more

Daewoong Pharma achieves significant milestone

Korea |  News | 0 Comment | 08 Jan, 2020

Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. South Korean firm Daewoong Pharmaceutical Co., Ltd. has announced ...Read more

Mundipharma, Biosolution to market CartiLife in South Korea

Korea |  News | 0 Comment | 07 Jan, 2020

Mundipharma has announced that it has sealed an exclusive sales agreement with Bio solution Co., Ltd, a Korea-based leader in cell-based biotechnology, to market and distribute its fourth-g...Read more

Nunaps raises $4.2M to develop digital platform for brain damage

Korea |  News | 0 Comment | 06 Jan, 2020

Nunaps, a South Korean digital therapeutics startup, has closed a KRW 5 billion (US$ 4.2 million) Series A round by Company K Partners, KTB Network, and K2 Investment Partners. T...Read more

Hana Pharm submits NDA for anesthetic agent

Korea |  News | 0 Comment | 31 Dec, 2019

Germany headquartered pharmaceutical company PAION AG has announced that its South Korean remimazolam licensee Hana Pharm has informed PAION about the submission of a New Drug Application (...Read more

Bridge Biotherapeutics announces CNMPA clearance of IND for BBT-401

Korea |  News | 0 Comment | 30 Dec, 2019

Bridge Biotherapeutics Inc. a clinical stage biotech company headquartered in Seongnam, Republic of Korea has announced that the Center for Drug Evaluation (CDE) of China's N...Read more

GenScript, Selecxine partner for novel antibody drug development

Korea |  News | 0 Comment | 27 Dec, 2019

The CDMO segment of the world's leading biotech company GenScript has announced that it has signed a strategic collaboration agreement with Selecxine Inc., a Korean biotech company dedicate...Read more

Bridge Biotherapeutics files Investigational NDA for NSCLC drug

Korea |  News | 0 Comment | 20 Dec, 2019

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company filed an Investigational New Drug (IND) applicatio...Read more

Alteogen inks license agreement for Hybrozyme Technology

Korea |  News | 0 Comment | 19 Dec, 2019

Korea based Alteogen Inc. has announced that it has entered into a non-exclusive global license agreement with a top 10 Global Pharmaceutical Company (GPC) to use ALT-B4, Alteogen&rsqu...Read more

Nicox signs agreement for ZERVIATE in South Korea

Korea |  News | 0 Comment | 17 Dec, 2019

French firm Nicox SA, an international ophthalmology company, has announced the signature of an exclusive license agreement with Samil Pharmaceutical Co., Ltd for the develop...Read more

TriNetX expands into South Korea in partnership with EvidNet

Korea |  News | 0 Comment | 16 Dec, 2019

US based TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), has expanded into&nbs...Read more